GE HealthCare unveils enhanced Voluson Expert Series women’s health ultrasound systems with focus on early detection and exam efficiency
28 Gennaio 2025 - 2:00PM
Business Wire
- Latest Voluson Expert 22, 20 and 18 ultrasound systems harness
artificial intelligence and advanced tools and software for more
efficient assessments
- Voluson Expert Series delivers elevated performance, with focus
on first trimester to reveal clearer anatomical details, aiding
earlier detection and boosting diagnostic confidence
GE HealthCare (Nasdaq: GEHC) today announced it has received
510(k) clearance from the United States Food and Drug
Administration (FDA) for the updated portfolio of Voluson™ Expert
Series ultrasound systems. Voluson Expert 22, 20 and 18 combine
high resolution image quality with advanced ultrasound technology
and an ergonomic design for efficient workflow and a world-class
user experience. The Voluson Expert Series integrates artificial
intelligence (AI)-powered features and automation tools to help
drive imaging performance and efficiencies in women’s
healthcare.
Approximately 30,000 to 50,000 women in the United States
experience complex, high-risk pregnancy each year.i When these
complications are left undetected or untreated, it may harm the
mother or the baby. The growing prevalence of these complicationsii
underscores the need for innovative solutions that enable early
detection and intervention.
The Voluson Expert Series, GE HealthCare’s most advanced women’s
health ultrasound systems, offers premium ultrasound imaging for
confident diagnoses for high risk, complex pregnancies. The Lyric
Architecture is designed to unlock new imaging and processing power
to deliver detailed and uniform images and reveal finer details
within the anatomy with ease, even in difficult scanning
conditions. AI-enabled functionality and automation tools are
available to support faster assessments and early detection,
diagnosis and intervention.
The SonoLyst suite of AI tools were designed to simplify exams
through image recognition and automated annotations and
measurements, increasing exam speed and accuracy. With this new
release, clinicians can now utilize SonoLystlive during 11 to
14-week anatomical exams helping ensure required views are captured
for diagnostic accuracy. In addition, Voluson Expert Series
ultrasound systems feature an expanded color Doppler offering,
Graphicflow, which provides a graphical representation of the
trajectories of the blood cells in real-time to visualize complex
blood flow quickly and clearly, helping users differentiate normal
from abnormal hemodynamics.
Voluson Expert Series also includes additional enhancements to
select Voluson AI tools:
- SonoPelvicFloor3.0 can help reduce pelvic floor measurement
exam time by 80%.* This feature now expands anatomical views, and
simplifies the exam process by automating plane alignment, live
C-plane tracking, and measurements.
- SonoAVCfollicle2.0 uses AI to increase accuracy and precision
in follicle detection, resulting in a better success rate of
detecting follicles, along with reduced artifacts and requiring
less time for postprocessing.
These systems are compatible with a wide selection of unique
specialty probes, including a new lightweight 2D/3D probe RAB7-D,
and wireless Vscan Air™ dual probes.
“We are proud to introduce these updates to the Voluson Expert
ultrasound systems, which represent our ongoing commitment to
advancing technology that addresses women's health needs of today,
and the future,” said Gerald Seifriedsberger, General Manager,
Women’s Health, Advanced Visualization Solutions, GE HealthCare.
“By introducing solutions that offer unparalleled clarity and
detail, we can empower users with critical insights for informed
care decisions and efficient exams, transforming how clinicians
approach healthcare. Together, we can create a healthier future for
all women.”
GE HealthCare will showcase the Voluson Expert series ultrasound
systems at the Society for Maternal-Fetal Medicine (SMFM) 2025
Pregnancy Meeting™ taking place on January 27-February 1 in Denver.
The Voluson Expert Series is available in the United States. For
more information on the Voluson Expert Series, visit:
https://www.gehealthcare.com/products/ultrasound/voluson.
*Versus manual exam
___________________________________
i Cleveland Clinic. High-Risk Pregnancy.
Cleveland Clinic.
https://my.clevelandclinic.org/health/diseases/22190-high-risk-pregnancy.
Last reviewed July 12, 2024. Accessed January 17, 2025.
ii Barfield WD, Besera G, Cox S, Warner L,
Azeez O, Riggs J, Russell R, Bowron S, Churchill RE. From Data to
Action: CDC's Public Health Surveillance for Women, Infants, and
Children. 2nd ed. Centers for Disease Control and Prevention; 2020.
https://www.cdc.gov/reproductive-health/media/pdfs/data-to-action/Data-To-Action_508.pdf.
Accessed January 17, 2025.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250127399513/en/
Eric Tatro Media Contact GE HealthCare +1 312 459 6140
Eric.Tatro@gehealthcare.com
Grafico Azioni GE HealthCare Technologies (NASDAQ:GEHC)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni GE HealthCare Technologies (NASDAQ:GEHC)
Storico
Da Mar 2024 a Mar 2025
